analyst
AR
NASDAQ · ARWR
Arrowhead Pharmaceuticals, Inc.
Healthcare · Biotechnology
$86.34
Down-$0.15 (-0.17%)
Updated Sep 7, 2026, 9:23 PM
SID Score
6.0/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 8.86B
- P/E ratio
- 43.81
- Dividend yield
- 0.00%
- 52-week range
- $27.94 – $95.49
- Volume
- 757.85K
- Avg. volume
- 3.18M
Price performance
ARWR price history
1M range · 20 trading sessions · Daily adjusted prices
ARWR closed at $86.34 after 20 trading sessions, down 2.25% for the selected period.
- Last close
- $86.34
- Period change
- -2.25%
- Period low
- $82.39
- Period high
- $89.41
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $85.87 | $86.96 | $84.2042 | $86.34 | 757.85K |
| Sep 3, 2026 | $85.18 | $86.79 | $83.46 | $86.49 | 1.37M |
| Sep 2, 2026 | $82.87 | $85.47 | $82.085 | $85.37 | 1.53M |
| Sep 1, 2026 | $81.14 | $83.27 | $80.76 | $82.74 | 1.33M |
| Aug 31, 2026 | $83.13 | $83.7554 | $80.75 | $82.39 | 1.6M |
| Aug 28, 2026 | $87.99 | $88.245 | $84.195 | $84.91 | 1.28M |
| Aug 27, 2026 | $89.59 | $89.59 | $88.06 | $88.59 | 857.52K |
| Aug 26, 2026 | $88.45 | $89.825 | $86.80 | $89.12 | 859.49K |
| Aug 25, 2026 | $88.00 | $90.211 | $87.00 | $88.88 | 983.04K |
| Aug 24, 2026 | $86.77 | $87.01 | $85.50 | $86.73 | 1.1M |
| Aug 21, 2026 | $87.90 | $88.46 | $85.94 | $87.11 | 1.09M |
| Aug 20, 2026 | $88.23 | $88.45 | $85.90 | $87.47 | 896.88K |
| Aug 19, 2026 | $89.51 | $90.00 | $87.58 | $89.41 | 1.36M |
| Aug 18, 2026 | $87.72 | $88.35 | $85.98 | $87.90 | 974.99K |
| Aug 17, 2026 | $86.44 | $88.94 | $86.26 | $88.70 | 930.07K |
| Aug 14, 2026 | $84.75 | $87.17 | $83.78 | $86.64 | 818.16K |
| Aug 13, 2026 | $87.60 | $88.055 | $84.76 | $85.59 | 1.1M |
| Aug 12, 2026 | $89.09 | $90.61 | $87.16 | $87.25 | 1.12M |
| Aug 11, 2026 | $88.94 | $90.97 | $88.45 | $89.24 | 1.04M |
| Aug 10, 2026 | $87.56 | $88.88 | $86.50 | $88.33 | 854.41K |
Latest ARWR news
The latest Smart Investors Daily articles mentioning ARWR.
Stock researchResearch & News · SEC Filings
Loading stock research…